BRICS push back against EU, US on drug patents
Research and development in China, India, Brazil and South Africa has made BRICS on the cutting edge of providing cheap medicines and saving lives, but pitting these countries at odds with the EU and US over patents [Xinhua]
BRICS member countries are likely to turn to the World Trade Organization in what is shaping up to be a dispute with the EU and US over pharmaceutical patents.